1. Analyst View 2. Research Methodology 3. US Clinical Laboratory Testing Market Outlook 2022 4. Market Segmentation by Test Type 4.1 Clinical Chemistry Laboratory 4.2 Human & Tumor Genetics Laboratory 4.3 Medical Microbiology & Cytology Laboratory 4.4 Esoteric Tests 5. Market Segmentation by Laboratories 5.1 Hospital Laboratories 5.2 Physician Laboratories 5.3 Independent Laboratories 6. Disease Demographics 7. Drivers & Trends 7.1 Growing Ageing Population 7.2 Rising Disease Incidence 7.3 Early Disease Detection Facilities 7.4 Employer Wellness Programs 7.5 Increased Health Care Spending 7.6 Collaboration & Consolidation 7.7 Focusing on Innovations 8. Key Players 8.1 Laboratory Corporation of America (LabCorp) 8.2 OPKO Health Inc. 8.3 Sonic Healthcare USA 8.4 Quest Diagnostics 8.5 Alere Inc. 8.6 Abbott Laboratories 8.7 Charles River Laboratories 8.8 Healthscope Ltd 8.9 Genzyme (Subsidiary of Sanofi) 8.10 Qiagen List of Figures: Figure 3-1: US - Clinical Laboratory Testing Market (Billion US$), 2016 & 2022 Figure 4-1: US - Clinical Laboratory Testing Market by Test Type (%), 2016 Figure 4-2: US - Clinical Chemistry Laboratory Testing Market (Billion US$), 2016 & 2022 Figure 4-3: US - Human & Tumor Genetics Laboratory Testing Market (Billion US$), 2016 & 2022 Figure 4-4: US - Medical Microbiology & Cytology Laboratory Testing Market (Billion US$), 2016 & 2022 Figure 4-5: US - Esoteric Laboratory Testing Market (Billion US$), 2016 & 2022 Figure 5-1: US - Clinical laboratory Testing Market Segment by Laboratories (%), 2016 Figure 5-2: US - Hospital Laboratory Testing Market (Billion US$), 2016 & 2022 Figure 5-3: US - Physician Laboratory Testing Market (Billion US$), 2016 & 2022 Figure 5-4: US - Independent Laboratory Testing Market (Billion US$), 2016 & 2022 Figure 7-1: US - Population 65 Years and Above (Million), 2016 & 2060 Figure 7-2: US - Prevalence of Cancer (Million), 2014 & 2024. Figure 7-3: US - Number of Closed M&A Deals in Lab Industry (2001-2013) Figure 8-1: LabCorp - Net Revenue by Segment (%), 2015 Figure 8-2: LabCorp - Net Revenue by Geography (%), 2015 Figure 8-3: OPKO Health Inc. - Revenue by Geography (%), 2015 Figure 8-4: Sonic Healthcare - Revenue by Segment (%), 2016 Figure 8-5: Sonic Health - Revenue by Geography (%), 2016 Figure 8-6: Alere Inc. - Revenue by Segment (%), 2015 Figure 8-7: Alere Inc. - Revenue by Geography (%), 2015 Figure 8-8: Abbott - Net Sales by Segment (%), 2015 Figure 8-9: Abbott - Net Sales by Geography (%), 2015 Figure 8-10: Charles River Laboratories - Revenue by Segment (%), 2015 Figure 8-11: Charles River Laboratories - Revenue by Geography (%), 2015 Figure 8-12: Healthscope Ltd. - Revenue by Segment (%), 2016 Figure 8-13: Sanofi - Net Sales by Geography (%), 2015 Figure 8-14: Qiagen - Net Sales by Segment (%), 2015 Figure 8-15: Qiagen - Net Sales by Geography (%), 2015 List of Tables: Table 6-1: US - Tuberculosis Incidences (2014 & 2015) Table 6-2: US - Influenza Incidences (2013 & 2014) Table 6-3: US - HIV/AIDS Incidences (2013 & 2014) Table 6-4: US - Gonorrhea Incidences (2013, 2014 & 2015) Table 6-5: US - Cirrhosis Incidences (2013 & 2014) Table 6-6: US - Kidney Diseases Incidences (2013 & 2014) Table 6-7: US - Cancer Incidences (2013, 2014 & 2015) Table 8-1: LabCorp - Financials (Million US$), 2013, 2014 & 2015 Table 8-2: OPKO - Financials (Million US$), 2013, 2014 & 2015 Table 8-3: Sonic Healthcare - Financials, (Million US$), 2014, 2015 & 2016 Table 8-4: Quest Diagnostics - Financials, (Million US$), 2013, 2014 & 2015 Table 8-5: Alere Inc. - Financials (Million US$), 2013, 2014 & 2015 Table 8-6: Abbott - Financials (Million US$), 2013, 2014 & 2015 Table 8-7: Charles River Laboratories - Financials (Million US$), 2013, 2014 & 2015 Table 8-8: Healthscope Ltd. - Financials (Million US$), 2014, 2015 & 2016 Table 8-9: Sanofi - Financials (Million US$), 2013, 2014 & 2015 Table 8-10: Qiagen - Financials (Million US$), 2013, 2014 & 2015